These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26453683)

  • 1. Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in Kuwait.
    Akhtar S; Alroughani R; Ahmed SF; Al-Hashel JY
    Mult Scler; 2016 Jul; 22(8):1086-93. PubMed ID: 26453683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term disability progression of pediatric-onset multiple sclerosis.
    McKay KA; Hillert J; Manouchehrinia A
    Neurology; 2019 Jun; 92(24):e2764-e2773. PubMed ID: 31092624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.
    Alroughani R; Ahmed SF; Al-Hashel J
    Pediatr Neurol; 2015 Dec; 53(6):508-12. PubMed ID: 26383244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and prevalence of pediatric onset multiple sclerosis in Kuwait: 1994-2013.
    Alroughani R; Akhtar S; Ahmed SF; Behbehani R; Al-Abkal J; Al-Hashel J
    J Neurol Sci; 2015; 353(1-2):107-10. PubMed ID: 25936254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the risk of secondary progression in multiple sclerosis.
    Koch M; Uyttenboogaart M; van Harten A; De Keyser J
    Mult Scler; 2008 Jul; 14(6):799-803. PubMed ID: 18573840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of secondary progressive multiple sclerosis.
    Koch M; Kingwell E; Rieckmann P; Tremlett H;
    J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):1039-43. PubMed ID: 20639385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.
    Kopp TI; Blinkenberg M; Petersen T; Sorensen PS; Magyari M
    Mult Scler Relat Disord; 2020 May; 40():101956. PubMed ID: 32007654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression in familial and nonfamilial MS.
    Koch M; Uyttenboogaart M; Heerings M; Heersema D; Mostert J; De Keyser J
    Mult Scler; 2008 Apr; 14(3):300-6. PubMed ID: 18208881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of paediatric-onset multiple sclerosis: a population-based study.
    Harding KE; Liang K; Cossburn MD; Ingram G; Hirst CL; Pickersgill TP; Te Water Naude J; Wardle M; Ben-Shlomo Y; Robertson NP
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):141-7. PubMed ID: 23154123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
    Roudbari SA; Ansar MM; Yousefzad A
    J Neurol Sci; 2013 Jul; 330(1-2):52-5. PubMed ID: 23628463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early predictors of conversion to secondary progressive multiple sclerosis.
    Barzegar M; Najdaghi S; Afshari-Safavi A; Nehzat N; Mirmosayyeb O; Shaygannejad V
    Mult Scler Relat Disord; 2021 Sep; 54():103115. PubMed ID: 34216997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapses and disability accumulation in progressive multiple sclerosis.
    Paz Soldán MM; Novotna M; Abou Zeid N; Kale N; Tutuncu M; Crusan DJ; Atkinson EJ; Siva A; Keegan BM; Pirko I; Pittock SJ; Lucchinetti CF; Weinshenker BG; Rodriguez M; Kantarci OH
    Neurology; 2015 Jan; 84(1):81-8. PubMed ID: 25398229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of primary progressive multiple sclerosis.
    Koch M; Kingwell E; Rieckmann P; Tremlett H
    Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
    Alroughani RA; Akhtar S; Ahmed SF; Al-Hashel JY
    Int J Neurosci; 2015; 125(11):831-7. PubMed ID: 25329929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H; Yinshan Zhao ; Devonshire V
    Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis in Belgian children: A multicentre retrospective study.
    Verhelst H; De Waele L; Deconinck N; Ceulemans B; Willekens B; Van Coster R
    Eur J Paediatr Neurol; 2017 Mar; 21(2):358-366. PubMed ID: 27818023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary progressive multiple sclerosis - clinical course and potential predictive factors.
    Pokryszko-Dragan A; Gruszka E; Bilińska M; Dubik-Jezierzańska M
    Neurol Neurochir Pol; 2008; 42(1):6-11. PubMed ID: 18365957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic indicators in pediatric clinically isolated syndrome.
    Iaffaldano P; Simone M; Lucisano G; Ghezzi A; Coniglio G; Brescia Morra V; Salemi G; Patti F; Lugaresi A; Izquierdo G; Bergamaschi R; Cabrera-Gomez JA; Pozzilli C; Millefiorini E; Alroughani R; Boz C; Pucci E; Zimatore GB; Sola P; Lus G; Maimone D; Avolio C; Cocco E; Sajedi SA; Costantino G; Duquette P; Shaygannejad V; Petersen T; Fernández Bolaños R; Paolicelli D; Tortorella C; Spelman T; Margari L; Amato MP; Comi G; Butzkueven H; Trojano M;
    Ann Neurol; 2017 May; 81(5):729-739. PubMed ID: 28439957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey.
    Alvarez E; Nair KV; Gorritz M; Bartolome L; Maloney H; Ding Y; Golan T; Wade RL; Kumar R; Su W; Shah R; Russo P
    Mult Scler Relat Disord; 2021 May; 50():102858. PubMed ID: 33799068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.